IDEXX Laboratories, Inc. IDXX | NASDAQ

$412.26 $3.23 | 0.79%

After Hours
$403.44 -$8.82 | -2.14%

Next Earnings: Feb 03, 2025

Company Overview:

Market Cap: $33.76B
PE Ratio: 39.83
52-Week Range: $398.5 - $583.39
Dividend Yield (FWD): 0.00% ($0.00)

10 Year Performance Metrics:

Total Return (with DRIP): 455.31% (18.70% / yr)
Total Return (no DRIP): 455.31% (18.70% / yr)
Share Price: 455.31%
Dividend Increase: nan%
IDXX 10-yr Total Return ($10,000 investment)
1Y 2Y 5Y 10Y All

IDXX Dividend Payments, Yield & Share Price charts

Dividend Payments & Yield
IDXX Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
Share Price
IDXX Price CAGR:1Y: -23.63%2Y: 0.80%5Y: 9.53%10Y: 18.72%

Unlock All Reports & Research Dividend Stocks like a BOSS!

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

IDXX Dividend Safety: Payout & Dividend to Free Cash Flow Ratios.

Dividend payout ration is Dividend/EPS, and indicates if company can afford to pay dividends from net income that it earned in the quarter.

Since EPS can be played with using different "accounting gymnastics", a better measure of dividends safety is Dividend to Free Cash Flow (FCF) ratio.

FCF is how much cash the company has earned each quarter, after paying all expenses not related to earnings.

Lower Ratio indicates SAFER Dividend! Ratios consistently close to, or over 100% are usually unsustainable and often indicate a dividend cut might be coming soon.

Dividend Payout Ratio - IDXX
14-Day FREE Trial Get Full Access Now!
Dividend to Free Cash Flow Ratio - IDXX
14-Day FREE Trial Get Full Access Now!

IDXX Earnings, Revenue, Cash & Debt, Shares Outstaning:

IDXX - EPS vs PE Ratio
14-Day FREE Trial Get Full Access Now!
IDXX - FCF vs FCF / Share
14-Day FREE Trial Get Full Access Now!
IDXX - EPS vs FCF / Share
14-Day FREE Trial Get Full Access Now!
IDXX - FCF vs Stock Based Comp
14-Day FREE Trial Get Full Access Now!
IDXX - Revenue vs Net Income
14-Day FREE Trial Get Full Access Now!
IDXX - Cash & Debt
14-Day FREE Trial Get Full Access Now!
IDXX - Revenue
14-Day FREE Trial Get Full Access Now!
IDXX Revenue CAGR:1Y: 6.56%2Y: 7.66%5Y: 10.02%10Y: 9.79%
IDXX - Earnings Per Share (EPS)
14-Day FREE Trial Get Full Access Now!
IDXX EPS CAGR:1Y: 10.67%2Y: 14.12%5Y: 17.69%10Y: 18.34%
IDXX - Net Income
14-Day FREE Trial Get Full Access Now!
IDXX Net Income CAGR:1Y: 9.71%2Y: 13.44%5Y: 16.43%10Y: 16.14%
IDXX - EBITDA
14-Day FREE Trial Get Full Access Now!
IDXX EBITDA CAGR:1Y: 24.24%2Y: 11.78%5Y: 16.07%10Y: 14.54%
IDXX - Free Cash Flow
14-Day FREE Trial Get Full Access Now!
IDXX Free Cash Flow CAGR:1Y: -19.45%2Y: 12.64%5Y: 15.12%10Y: 9.69%
IDXX - Free Cash Flow / Share
14-Day FREE Trial Get Full Access Now!
IDXX Free Cash Flow / Share CAGR:1Y: -18.67%2Y: 13.28%5Y: 16.19%10Y: 11.79%
IDXX - Gross Profit
14-Day FREE Trial Get Full Access Now!
IDXX Gross Profit CAGR:1Y: 8.77%2Y: 8.47%5Y: 11.56%10Y: 10.82%
IDXX - Expenses
14-Day FREE Trial Get Full Access Now!
IDXX Expenses CAGR:1Y: -17.61%2Y: -13.67%5Y: -5.53%10Y: 5.09%
IDXX - Shares Outstanding
14-Day FREE Trial Get Full Access Now!
IDXX Shares Outstanding CAGR:1Y: -1.12%2Y: -0.63%5Y: -1.07%10Y: -1.92%
IDXX - Share Buybacks
14-Day FREE Trial Get Full Access Now!
IDXX Share Buybacks CAGR:1Y: 525.36%2Y: 13.03%5Y: 20.68%10Y: -2.08%
IDXX - Stock-Based Comp
14-Day FREE Trial Get Full Access Now!
IDXX Stock-Based Comp CAGR:1Y: 4.56%2Y: 10.88%5Y: 11.13%10Y: 13.11%
IDXX - Dividends
14-Day FREE Trial Get Full Access Now!
IDXX Dividend CAGR:1Y: N/A2Y: N/A5Y: N/A10Y: N/A
IDXX - Revenue by Segment
14-Day FREE Trial Get Full Access Now!
IDXX Revenue CAGR:1Y: 6.56%2Y: 7.66%5Y: 10.02%10Y: 9.79%

Revenue, EPS, Net Income & Ebitda - Estimates VS Actual:

IDXX - REVENUE: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IDXX Actual Revenue CAGR:1Y: 6.56%2Y: 7.66%5Y: 10.02%10Y: 9.79%
IDXX - EPS: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IDXX Actual EPS CAGR:1Y: 10.67%2Y: 14.12%5Y: 17.69%10Y: 18.34%
IDXX - NET INCOME: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IDXX Actual Net Income CAGR:1Y: 9.71%2Y: 13.44%5Y: 16.43%10Y: 16.14%
IDXX - EBITDA: Actual + Estimates
14-Day FREE Trial Get Full Access Now!
IDXX Actual EBITDA CAGR:1Y: 24.24%2Y: 11.78%5Y: 16.07%10Y: 14.54%

Ratios, Profit Margins & Return on Capital:

IDXX - Net Profit Margin
14-Day FREE Trial Get Full Access Now!
IDXX Net Profit Margin CAGR:1Y: 2.98%2Y: 5.37%5Y: 5.83%10Y: 5.79%
IDXX - Gross Profit Margin
14-Day FREE Trial Get Full Access Now!
IDXX Gross Profit Margin CAGR:1Y: 2.09%2Y: 0.75%5Y: 1.40%10Y: 0.94%
IDXX - Price to Earnings
14-Day FREE Trial Get Full Access Now!
IDXX - Price To Sales Ratio
14-Day FREE Trial Get Full Access Now!
IDXX - Return on Capital Employed
14-Day FREE Trial Get Full Access Now!
IDXX - Return on Invested Capital
14-Day FREE Trial Get Full Access Now!

Compare stocks side-by-side
 

IDXX Dividends Info:

Annual Dividend: $
Forward Yield: 0%
Ex-Dividend Date:
Lifetime Dividens / Share: $0.00

IDXX Dividend History: Dates, Payments & Yield list

Below is a schedule of all IDXX dividend payments, ex-dates, share price on the day of the payment as well as TTM & forward yield

Ex-Date Payment Date Amount TTM Yield Forward Yield Price on Ex-Date

Get the best Dividend Stock Research Tools:

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial

Projected Future Returns & Dividends for IDXX

Based on past 10-year performance, here are IDXX growth metrics:

Share price CAGR of +18.7%
Dividend CAGR of +0%
Using IDXX CAGR metrics, we can estimate, that your initial $10000 investment, over next 10 years ago, should grow with dividends being reinvested (DRIP) as follows:

IDXX
Current Price$412.26
Start Shares24.26
Start Value$10,000
 
After 10 years:
Final Share Count24.26
Dividends Payment$0.00
Annual Dividends$0
Yield on cost0.00%
Share Price$1,928.64
Total Dividends$0
Final Value$46,782

Estimated Future Value + Dividends - IDXX

NOTE: Above numbers are our estimate based on IDXX's Dividend and Price CAGR over past 10 years. These numebrs should only be considered as "potential future returns"! These numbers assume DRIP (reinvesting dividends).

We cannot guarantee that your actual returns will meet these estimates.

Company Info

IDEXX Laboratories, Inc. (IDXX) had its IPO on 1991-06-21, and is trader on NASDAQ stock exchange.

IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory animal diagnostic instruments and services for biomedical research community. The company also offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; and point-of-care electrolytes and blood gas analyzers and SARS-CoV-2 RT-PCR that are used in the human point-of-care medical diagnostics market; in-clinic chemistry, blood and urine chemistry, hematology, and SediVue Dx analyzers; SNAP rapid assays test kits. In addition, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; veterinary software and services for independent veterinary clinics and corporate groups. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

IDXX website: https://www.idexx.com


Get Full Access to All Reports with DRIPCalc PRO

Monthly
$15/mo
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial
Yearly - 33% OFF
$120/yr
14-days Free Trial.
Unlimited Access to dividend stocks reports & multiple metrics, for Dividend-oriented Investors.
Visual Stock Research
Stock Comparison Tools
Dividend Stocks & ETFs
Revenue & EPS Estimates
Custom Dividend Reports
Start Free Trial